SANA Sana Biotechnology Inc

Price (delayed)

$2.95

Market cap

$820.96M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.93

Enterprise value

$808.29M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 3

Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and ...

Highlights
SANA's debt is down by 18% year-on-year and by 4.5% since the previous quarter
The EPS has declined by 6% year-on-year but it is up by 3.1% since the previous quarter
SANA's quick ratio has plunged by 63% YoY and by 33% from the previous quarter
The equity has contracted by 43% YoY and by 26% from the previous quarter

Key stats

What are the main financial stats of SANA

SANA stock price

How has the Sana Biotechnology stock price performed over time
Intraday
-5.45%
1 week
-5.75%
1 month
-13.49%
1 year
27.16%
YTD
-27.52%
QTD
2.43%

Financial performance

How have Sana Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$248.3M
Net income
-$241.99M
Gross margin
N/A
Net margin
N/A
The operating income has contracted by 17% YoY
The net income is down by 16% year-on-year

Price vs fundamentals

How does SANA's price correlate with its fundamentals

Growth

What is Sana Biotechnology's growth rate over time

Valuation

What is Sana Biotechnology stock price valuation
P/E
N/A
P/B
6.6
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 6% year-on-year but it is up by 3.1% since the previous quarter
SANA's P/B is 105% above its 5-year quarterly average of 3.4 and 25% above its last 4 quarters average of 5.6
The equity has contracted by 43% YoY and by 26% from the previous quarter

Efficiency

How efficient is Sana Biotechnology business performance
The company's return on invested capital has shrunk by 125% YoY and by 23% QoQ
The return on equity has dropped by 112% year-on-year and by 14% since the previous quarter
Sana Biotechnology's ROA has plunged by 55% YoY and by 3.6% from the previous quarter

Dividends

What is SANA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SANA.

Financial health

How did Sana Biotechnology financials performed over time
The company's total assets is 47% higher than its total liabilities
SANA's quick ratio has plunged by 63% YoY and by 33% from the previous quarter
The current ratio has plunged by 62% YoY and by 32% from the previous quarter
SANA's debt is 37% smaller than its equity
The debt to equity rose by 43% year-on-year and by 29% since the previous quarter
The equity has contracted by 43% YoY and by 26% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.